{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:50:45Z","timestamp":1792043445516,"version":"4.4.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.semarthrit.2021.07.011","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T03:54:58Z","timestamp":1625802898000},"page":"1147-1161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?"],"prefix":"10.1016","volume":"51","author":[{"given":"Dennis","family":"McGonagle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel Z.","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Marzo-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihi","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coziana","family":"Ciurtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.semarthrit.2021.07.011_bib0001","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.07.011_bib0002","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/ard.59.12.985","article-title":"Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response?","volume":"59","author":"Braun","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0003","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/acr.23534","article-title":"Characterization of patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis in the US-based Corrona registry","volume":"70","author":"Mease","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Pt 5","key":"10.1016\/j.semarthrit.2021.07.011_bib0004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1469-7580.2001.19950503.x","article-title":"The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites","volume":"199","author":"Benjamin","year":"2001","journal-title":"J Anat"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.011_bib0005","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/art.22758","article-title":"The concept of a \"synovio-entheseal complex\" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond","volume":"56","author":"McGonagle","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/ard.30.3.213","article-title":"Enthesopathy of rheumatoid and ankylosing spondylitis","volume":"30","author":"Ball","year":"1971","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0007","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00002281-199607000-00003","article-title":"The sacroiliac joint in the spondyloarthropathies","volume":"8","author":"Braun","year":"1996","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0008","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780370709","article-title":"Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients","volume":"37","author":"Braun","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/art.10125","article-title":"The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy","volume":"46","author":"McGonagle","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0012","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/acr.23249","article-title":"Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the corrona psoriatic arthritis\/spondyloarthritis registry","volume":"69","author":"Mease","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0013","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr2.11154","article-title":"Characterization of patients with axial spondyloarthritis by enthesitis presence: data from the corrona psoriatic arthritis\/spondyloarthritis registry","volume":"2","author":"Mease","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0014","article-title":"Assessing the humanistic and economic burden of enthesitis among patients with peripheral and axial spondyloarthritis: results from a multi-national real world survey database","volume":"71","author":"Strand","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000482","article-title":"Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort","volume":"3","author":"Ruyssen-Witrand","year":"2017","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0016","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.140878","article-title":"Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis","volume":"41","author":"Orbai","year":"2014","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0017","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","article-title":"Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI group","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0019","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3899\/jrheum.190540","article-title":"Entheseal changes in response to age, body mass index, and physical activity: an ultrasound study in healthy people","volume":"47","author":"Bakirci","year":"2020","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.011_bib0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/acr.20496","article-title":"Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0021","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.40423","article-title":"The association between HLA genetic susceptibility markers and sonographic enthesitis in psoriatic arthritis","volume":"70","author":"Polachek","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0022","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2018.02668","article-title":"The early phases of ankylosing spondylitis: emerging insights from clinical and basic science","volume":"9","author":"Watad","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0023","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","article-title":"The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies","volume":"78","author":"McGonagle","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.40728","article-title":"Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0026","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0027","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2019-215210","article-title":"Evidence that tissue resident human enthesis gammadeltaT-cells can produce IL-17A independently of IL-23R transcript expression","volume":"78","author":"Cuthbert","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0028","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3389\/fimmu.2018.01550","article-title":"The initiation, but not the persistence, of experimental spondyloarthritis is dependent on interleukin-23 signaling","volume":"9","author":"van Tok","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0029","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3899\/jrheum.100146","article-title":"Frequency and phenotype of T helper 17 cells in peripheral blood and synovial fluid of patients with reactive arthritis","volume":"37","author":"Shen","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0030","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/s41467-017-01771-2","article-title":"Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis","volume":"8","author":"Al-Mossawi","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.07.011_bib0031","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0032","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3899\/jrheum.151133","article-title":"Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis","volume":"43","author":"Hayashi","year":"2016","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0033","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39732","article-title":"Interleukin-23-dependent gamma\/delta T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice","volume":"68","author":"Reinhardt","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"Mar 11","key":"10.1016\/j.semarthrit.2021.07.011_bib0034","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1038\/ncomms10928","article-title":"IL-17-producing gammadelta T cells enhance bone regeneration","volume":"7","author":"Ono","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0036","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/14397595.2013.850182","article-title":"Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis","volume":"24","author":"Rezvani","year":"2014","journal-title":"Modern rheumatology"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0037","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/art.23969","article-title":"Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial","volume":"58","author":"Inman","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2021.07.011_bib0038","first-page":"873","article-title":"Secukinumab provides sustained improvement of enthesitis in patients with ankylosoing spondylitis: pooled analysis of four pivotal phase 3 studies (Abstract FRI0380)","volume":"78","author":"Schett","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0039","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.40866","article-title":"A fifty-two-week, randomized, placebo-controlled trial of certolizumab pegol in nonradiographic axial spondyloarthritis","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7555\/JBR.31.20160088","article-title":"Ultrasonographic evaluation of enthesitis in patients with ankylosing spondylitis","volume":"31","author":"Zhang","year":"2017","journal-title":"J Biomed Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0041","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis","volume":"18","author":"de Winter","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0042","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3899\/jrheum.171094","article-title":"Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the corrona psoriatic arthritis\/spondyloarthritis registry","volume":"45","author":"Mease","year":"2018","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000802","article-title":"Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis","volume":"5","author":"de Winter","year":"2019","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0044","first-page":"561","article-title":"Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort","volume":"37","author":"Nadon","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/annrheumdis-2013-204239","article-title":"Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination","volume":"74","author":"Poggenborg","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0046","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/acr.23174","article-title":"Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics, and outcome","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0047","unstructured":"Behrens F, Sewerin P, De Miguel E, et\u00a0al. Achilles tendon enthesitis and disease burden in psoriatic arthritis and axial spondyloarthritis: baseline results from a randomized controlled trial. Poster 2503 presented at the Annual Meeting of the American College of Rheumatology (ACR); 8-13 November 2019; Atlanta, GA, USA. 2019."},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0048","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00296-015-3360-8","article-title":"A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes","volume":"36","author":"Aydin","year":"2016","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0049","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-017-1399-5","article-title":"The association between sonographic enthesitis and radiographic damage in psoriatic arthritis","volume":"19","author":"Polachek","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semarthrit.2019.06.016","article-title":"Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis","volume":"50","author":"Solmaz","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0051","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.40753","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0052","article-title":"Improvement of signs and symptoms of nonradiographic axial spondyloarthritis in patients treated with secukinumab: primary results of a randomized, placebo-controlled phase III study","author":"Deodhar","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0053","first-page":"27","article-title":"Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults","volume":"38","author":"Erdes","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 10","key":"10.1016\/j.semarthrit.2021.07.011_bib0054","article-title":"Ixekizumab improves signs and symptoms of patients with radiographic and non-radiographic axial spondyloarthritis and extra-articular manifestation of enthesitis through 16 week [abstract]","volume":"72","author":"Schett","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/annrheumdis-2020-216980","article-title":"Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study","volume":"79","author":"van der Heijde","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0056","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","article-title":"Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0057","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/annrheumdis-2013-203559","article-title":"Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials","volume":"73","author":"Sieper","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0058","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/ard.2004.020800","article-title":"Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study","volume":"63","author":"Tan","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0059","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/ard.2010.145946","article-title":"Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10162","key":"10.1016\/j.semarthrit.2021.07.011_bib0060","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","article-title":"Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.011_bib0061","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","article-title":"Tofacitinib in patients with ankylosing spondylitis: a phase III, 16-week, randomised, placebo-controlled, dose-ranging study","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0062","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3899\/jrheum.180718","article-title":"Safety and efficacy of intravenous golimumab in adults with ankylosing spondylitis: results through 1 year of the GO-ALIVE study","volume":"46","author":"Reveille","year":"2019","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0063","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3899\/jrheum.170487","article-title":"Safety and efficacy of golimumab administered intravenously in adults with ankylosing spondylitis: results through week 28 of the GO-ALIVE study","volume":"45","author":"Deodhar","year":"2018","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0064","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3899\/jrheum.170408","article-title":"Whole-body magnetic resonance imaging in axial spondyloarthritis: reduction of sacroiliac, spinal, and entheseal inflammation in a placebo-controlled trial of adalimumab","volume":"45","author":"Krabbe","year":"2018","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0065","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/kex174","article-title":"Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA","volume":"56","author":"van der Heijde","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0066","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","article-title":"Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study","volume":"73","author":"Landewe","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0067","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3899\/jrheum.160584","article-title":"Ultrasound evaluation of the entheses in daily clinical practice during tumor necrosis factor-alpha blocking therapy in patients with ankylosing spondylitis","volume":"44","author":"Wink","year":"2017","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0068","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3899\/jrheum.150659","article-title":"Comparison of clinical examination versus whole-body magnetic resonance imaging of enthesitis in patients with early axial spondyloarthritis during 3 years of continuous etanercept treatment","volume":"43","author":"Althoff","year":"2016","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0069","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3899\/jrheum.140056","article-title":"Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial","volume":"41","author":"Song","year":"2014","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/annrheumdis-2011-201010","article-title":"Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial","volume":"71","author":"Song","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0071","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","article-title":"Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial","volume":"70","author":"Song","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0072","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/art.39257","article-title":"A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis","volume":"67","author":"Sieper","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0073","first-page":"844","article-title":"Colour Doppler ultrasonography can be used to detect the changes of sacroiliitis and peripheral enthesitis in patients with ankylosing spondylitis during adalimumab treatment","volume":"33","author":"Hu","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0074","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10067-015-2939-5","article-title":"Performance of ultrasound to monitor Achilles enthesitis in patients with ankylosing spondylitis during TNF-a antagonist therapy","volume":"34","author":"Wang","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2012-202533","article-title":"Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial","volume":"73","author":"Huang","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0076","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/kes251","article-title":"Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)","volume":"52","author":"van der Heijde","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0077","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0078","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/s10165-011-0557-x","article-title":"A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis","volume":"22","author":"Kobayashi","year":"2012","journal-title":"Modern rheumatology"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0079","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/rheumatology\/ker194","article-title":"Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years\u2013early clinical response predicts long-term outcome","volume":"50","author":"Baraliakos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0080","first-page":"642","article-title":"Efficacy and safety of ultrasound-guided local injections of etanercept into entheses of ankylosing spondylitis patients with refractory Achilles enthesitis","volume":"29","author":"Huang","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0081","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/kep410","article-title":"Monitoring Achilles enthesitis in ankylosing spondylitis during TNF-alpha antagonist therapy: an ultrasound study","volume":"49","author":"Aydin","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.011_bib0082","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/ard.2009.121533","article-title":"A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial","volume":"69","author":"Dougados","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0083","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar2953","article-title":"Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis","volume":"12","author":"Rudwaleit","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0084","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/art.22236","article-title":"Switching from infliximab to once-weekly administration of 50mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study","volume":"55","author":"Cantini","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0085","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/art.21913","article-title":"Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0086","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/ard.2007.087270","article-title":"Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0087","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/ard.2004.022582","article-title":"Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study","volume":"64","author":"Marzo-Ortega","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0088","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","article-title":"Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)","volume":"52","author":"van der Heijde","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0089","first-page":"672","article-title":"The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab","volume":"29","author":"Heldmann","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0090","first-page":"184","article-title":"Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety","volume":"34","author":"Heldmann","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0091","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/art.11017","article-title":"Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis","volume":"48","author":"Brandt","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0092","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.24001","article-title":"Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period","volume":"59","author":"Braun","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0093","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/rheumatology\/keh584","article-title":"Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years","volume":"44","author":"Braun","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"9313","key":"10.1016\/j.semarthrit.2021.07.011_bib0094","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.011_bib0095","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/art.11104","article-title":"Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0096","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ard.2004.025130","article-title":"Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis","volume":"64","author":"Braun","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.semarthrit.2021.07.011_bib0097","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0098","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H","article-title":"Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study","volume":"44","author":"Marzo-Ortega","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0099","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/ard.2008.092213","article-title":"MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib","volume":"68","author":"Jarrett","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0100","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/ard.2004.029611","article-title":"Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis","volume":"64","author":"Gossec","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0101","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/030097401753180318","article-title":"Clinical investigation of methotrexate in the treatment of ankylosing spondylitis","volume":"30","author":"Altan","year":"2001","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0102","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3899\/jrheum.180797","article-title":"Treatment of dactylitis and enthesitis in psoriatic arthritis with biologic agents: a systematic review and metaanalysis","volume":"47","author":"Mourad","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0103","article-title":"Associations of HLA-B alleles, enthesitis and peripheral arthritis in ankylosing spondylitis","volume":"71","author":"Naovarat","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0104","doi-asserted-by":"crossref","unstructured":"Kristensen S, Christensen JH, Schmidt EB, et\u00a0al. Assessment of enthesitis in patients with psoriatic arthritis using clinical examination and ultrasound. Muscles Ligaments Tendons J.2016;6(2):241\u20137. doi: 10.11138\/mltj\/2016.6.2.241.","DOI":"10.11138\/mltj\/2016.6.2.241"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0105","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.190169","article-title":"The relationship between physical examination and ultrasonography of large entheses of the achilles tendon and patellar tendon origin","volume":"47","author":"Aydin","year":"2020","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0106","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/ard.46.3.197","article-title":"Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis","volume":"46","author":"Mander","year":"1987","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0107","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/ard.2007.084244","article-title":"Development and validation of the spondyloarthritis research consortium of Canada (SPARCC) enthesitis index","volume":"68","author":"Maksymowych","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.07.011_bib0108","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.23568","article-title":"Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis","volume":"59","author":"Healy","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0109","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.62.2.127","article-title":"Assessment of enthesitis in ankylosing spondylitis","volume":"62","author":"Heuft-Dorenbosch","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.07.011_bib0110","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.1780391209","article-title":"Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0111","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.semarthrit.2018.05.011","article-title":"Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study","volume":"48","author":"Araujo","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42358-019-0066-8","article-title":"Correlation of enthesitis indices with disease activity and function in axial and peripheral spondyloarthritis: a cross-sectional study comparing MASES, SPARCC and LEI","volume":"59","author":"Palominos","year":"2019","journal-title":"Adv Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2021.07.011_bib0113","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0114","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/rheumatology\/kew223","article-title":"BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics","volume":"56","author":"Hamilton","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0115","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0116","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 Update of the American College of Rheumatology\/spondylitis association of America\/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.07.011_bib0118","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Assessment of spondylo arthritis international S. Ankylosing spondylitis disease activity score (ASDAS): 2018 update of the nomenclature for disease activity states","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.07.011_bib0119","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.07.011_bib0120","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jbspin.2016.11.013","article-title":"Patient and physician agreement on reported bath ankylosing spondylitis disease activity index in patients with axial spondyloarthritis","volume":"84","author":"Ghukasyan","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0121","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.39458","article-title":"Review: enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment","volume":"68","author":"Kehl","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0122","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0123","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/rheumatology\/ker284","article-title":"Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis","volume":"50","author":"Spadaro","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0124","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/kev233","article-title":"Limited ultrasound protocol of the Achilles enthesis","volume":"54","author":"Aydin","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11926-018-0751-3","article-title":"Enthesitis: much more than focal insertion point inflammation","volume":"20","author":"Watad","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.07.011_bib0126","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/ard.2010.138701","article-title":"How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography","volume":"70","author":"D'Agostino","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.07.011_bib0127","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.crad.2012.07.018","article-title":"The use of ultrasound for the assessment of enthesitis in patients with spondyloarthritis","volume":"68","author":"Eder","year":"2013","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.07.011_bib0128","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000686","article-title":"Can power Doppler ultrasound of the entheses help in classifying recent axial spondyloarthritis? Data from the DESIR cohort","volume":"4","author":"Poulain","year":"2018","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0129","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3899\/jrheum.181083","article-title":"Utility of magnetic resonance imaging in diagnosis and monitoring enthesitis in patients with spondyloarthritis: an OMERACT systematic literature review","volume":"46","author":"Mathew","year":"2019","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.07.011_bib0130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3899\/jrheum.181084","article-title":"Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)","volume":"46","author":"Krabbe","year":"2019","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.07.011_bib0131","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3899\/jrheum.161114","article-title":"Whole-body magnetic resonance imaging in inflammatory arthritis: systematic literature review and first steps toward standardization and an OMERACT scoring system","volume":"44","author":"Ostergaard","year":"2017","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.07.011_bib0132","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1754-9485.12573","article-title":"Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand","volume":"61","author":"Truong","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.07.011_bib0133","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00256-005-0071-3","article-title":"Assessment of enthesitis in ankylosing spondylitis by power Doppler ultrasonography","volume":"35","author":"Kiris","year":"2006","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.semarthrit.2021.07.011_bib0134","doi-asserted-by":"crossref","unstructured":"Michelsen B, Diamantopoulos AP, Soldal DM, Hammer HB, Kavanaugh A, Haugeberg G. Achilles enthesitis defined by ultrasound is not associated with clinical enthesitis in patients with psoriatic arthritis. RMD Open.2017;3(2):e000486. https:\/\/doi.org\/10.1136\/rmdopen-2017-000486.","DOI":"10.1136\/rmdopen-2017-000486"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.07.011_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/03009742.2017.1393695","article-title":"Modification of a sonographic enthesitis score to differentiate between psoriatic arthritis and young healthy volunteers","volume":"47","author":"Wervers","year":"2018","journal-title":"Scand J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T20:58:23Z","timestamp":1699217903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221001359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":135,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0049017221001359"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.011","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}